non-small cell lung cancerNSCLCchemotherapy
…ological distress and quality of life (QoL) among patients with non-small cell lung cancer (NSCLC) receiving chemotherapy and examine the relationship bet…
189articles mentioning diseases
777disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: NSCLC ×
NSCLC
This disease is selected. Its supporting articles are shown below.
Articles mentioning NSCLC
189 articles · page 5 of 16Non-small cell lung cancerNSCLCChemoradiotherapy[18F] FDGAmerican College of Radiology Imaging Network[18F]Fluorodeoxyglucose[18F]FDG[18F] fluorodeoxyglucoseCancer Imaging Archive
…aortic blood poolAbstract 35 Figure 1Graphical abstract. NSCLC: Non-small cell lung cancer, PET: Positron Emission Tomography, CT: Computed Tomography, [1…
NSCLCmetastatic non-small cell lung canceripilimumabnivolumabIPINIVO
…ers than in progressors.Conclusions In patients with metastatic NSCLC and low or negative tumor PD-L1 expression, IPI/NIVO/RT was abl…
NSCLCnon-small cell lung cancertucidinostatimmunotherapyanti-angiogenic therapy
…suppressing YAP activity. In two elderly patients with advanced NSCLC who had developed acquired resistance to immunotherapy, the com…
NSCLCadvanced non-small cell lung cancerchemotherapyICIs
…nd women treated with ICIs versus chemotherapy for stage III–IV NSCLC. Eligible studies compared programmed cell death protein 1/prog…
oligometastatic NSCLCstage IV lung cancerstage IV NSCLCNSCLConcogene-driven NSCLClung cancerbrigatinibosimertinibNational Institute for Clinical Excellence
…assert that surgery before progression for patients with stable oligometastatic NSCLC is at risk of remaining undiscussed and unduly delayed while th…
lung cancerNSCLCShanghai Chest Hospitalbevacizumabintrathecal pemetrexedchemotherapyCohort A
…mprove symptoms and confer a survival benefit in non-small cell lung cancer (NSCLC) patients with LM, drug resistance remains a significant…
NSCLCnon-small-cell lung cancerAdenocarcinomapembrolizumabdurvalumabnivolumabICIsimmune checkpoint inhibitors
…x (PNI), and lactate dehydrogenase (LDH) levels in very elderly NSCLC patients receiving immune checkpoint inhibitors (ICIs), and its…
NSCLCnon-small-cell lung cancerosimertinibnintedanibalectinibquaternary-care hospital
…a cardiovascular history.Conclusion and Relevance Patients with NSCLC treated with oral antineoplastic agents exhibit a high baseline…
NSCLCnon-small cell lung cancerdocetaxeldatopotamab deruxtecanplatinum-based chemotherapy
…ibody, gotistobart (ONC-392/BNT316) in patients with metastatic NSCLC resistant to immunotherapy is on the way (NCT05671510); moreove…
NSCLCnon-small cell lung cancerneoadjuvant treatmentUniversity of VeronaClinicalTrials.govsurgeryClinicaltrial.govadjuvant treatment
…aly, comprising two cohorts of patients affected by early stage NSCLC (stages IB–IIIA) epidermal growth factor receptor and anaplasti…
NSCLCNon-small cell lung cancersolid malignanciesAnti-PD-(L)1santi-PD-(L)1anti-PD-(L)1-basedAmerican Society of Clinical Oncology
…DFS/PFS presented R² 0.39 across all RCTs (51 ICs), and 0.65 in NSCLC (21 ICs; p<0.01).Conclusions Early use of anti-PD-(L)1 therapy …